ESMO and ASCO publish joint consensus statement on streamlining clinical research By Ogkologos - October 28, 2026 16 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer Bringing AI to the data: the future of privacy-compliant cancer research MOST POPULAR Cancer Control in American Indian and Alaska Native Populations: A Conversation... April 25, 2018 Students Invent Disposable Core Biopsy Needle to Make the Procedure Cheaper May 21, 2019 New study to detect oesophageal cancer earlier April 28, 2022 Study Suggests Statins May Help Keep Breast Cancer from Spreading to... June 24, 2020 Load more HOT NEWS Hugh Jackman Stops His Show To Bring Woman With Breast Cancer... ESMO Launches Living Guidelines to Enhance the Usability of its Clinical... Molecular Analysis for Precision Oncology Congress 2023, 4–6 October 2023 Paris,... Although Not Improving DFS, Adjuvant Avelumab May Potentially Reduce the Risk...
